Authors: Mathijssen, RHJ van Alphen, RJ Verweij, J Loos, WJ Nooter, K Stoter, G Sparreboom, A

Citation: Rhj. Mathijssen et al., Clinical pharmacokinetics and metabolism of irinotecan (CPT-11), CLIN CANC R, 7(8), 2001, pp. 2182-2194

Authors: de Jonge, MJA Verweij, J de Bruijn, P Brouwer, E Mathijssen, RHJ van Alphen, RJ de Boer-Dennert, MM Vernillet, L Jacques, C Sparreboom, A

Citation: Mja. De Jonge et al., Pharmacokinetic, metabolic, and pharmacodynamic profiles in a dose-escalating study of irinotecan and cisplatin, J CL ONCOL, 18(1), 2000, pp. 195-203

Authors: Mathijssen, RHJ van Alphen, RJ de Jonge, MJA Verweij, J de Bruijn, P Loos, WJ Nooter, K Vernillet, L Stoter, G Sparreboom, A

Citation: Rhj. Mathijssen et al., Sparse-data set analysis for irinotecan and SN-38 pharmacokinetics in cancer patients co-treated with cisplatin, ANTI-CANC D, 10(1), 1999, pp. 9-16